Literature DB >> 3039352

Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line.

W D Cook, B Fazekas de St Groth, J F Miller, H R MacDonald, R Gabathuler.   

Abstract

Abelson murine leukemia virus (A-MuLV) carries the gene v-abl, one of a group of oncogenes with structural and functional (tyrosine kinase) homology to three growth factor receptors. Work in this and other laboratories has shown that A-MuLV infection can render myeloid and lymphoid cells independent of the growth factors interleukin 3 and granulocyte-macrophage colony-stimulating factor. We have now shown that v-abl can also relieve interleukin 2 (IL-2) dependence in T cells. We infected a cloned IL-2-dependent antigen-specific cell line. Transformed cells were generated which were factor independent and tumorigenic. The transformants each bore unique v-abl DNA inserts and expressed v-abl mRNA. No elevation of expression of either IL-2 or its receptor could be detected in these cells. Thus, A-MuLV can short-circuit the dependence of hematopoietic cells on IL-2, IL-3, and possibly granulocyte-macrophage colony-stimulating factor, none of whose receptors are known to be of the tyrosine kinase type.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039352      PMCID: PMC365403          DOI: 10.1128/mcb.7.7.2631-2635.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues.

Authors:  T J Gonda; D K Sheiness; J M Bishop
Journal:  Mol Cell Biol       Date:  1982-06       Impact factor: 4.272

2.  Structure of the Abelson murine leukemia virus genome.

Authors:  A Shields; S Goff; M Paskind; G Otto; D Baltimore
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

3.  Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.

Authors:  S P Goff; E Gilboa; O N Witte; D Baltimore
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

7.  Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine.

Authors:  O N Witte; A Dasgupta; D Baltimore
Journal:  Nature       Date:  1980-02-28       Impact factor: 49.962

8.  Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA.

Authors:  A Srinivasan; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Resistance of cultures of normal T cells to infection with murine type C viruses.

Authors:  I Horak; L Enjuanes; J C Lee; J N Ihle
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Following the cytokine signaling pathway to leukemogenesis: a chronology.

Authors:  Kendall A Smith; James D Griffin
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

2.  Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Authors:  G Q Daley; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Activated lck tyrosine protein kinase stimulates antigen-independent interleukin-2 production in T cells.

Authors:  K Luo; B M Sefton
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

4.  Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.

Authors:  M Kelliher; A Knott; J McLaughlin; O N Witte; N Rosenberg
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

5.  SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.

Authors:  A M Pendergast; M L Gishizky; M H Havlik; O N Witte
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line.

Authors:  J C Young; M L Gishizky; O N Witte
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

7.  Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors.

Authors:  C Laker; G Gräning; A Kelso; C Stocking; W Ostertag
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

8.  Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.

Authors:  M W Renshaw; E T Kipreos; M R Albrecht; J Y Wang
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

Review 9.  Dysregulation of growth factor-receptor system in cellular transformation.

Authors:  M Hatakeyama; T Taniguchi
Journal:  Jpn J Cancer Res       Date:  1988-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.